- Home
- GPCR
as 04-23-2025 4:00pm EST
Stocks
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 1.1B | IPO Year: | 2023 |
| Target Price: | $80.71 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $13.22 - $62.74 | Next Earning Date: | 05-08-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Structure Therapeutics Inc. News
GPCR Breaking Stock News: Dive into GPCR Ticker-Specific Updates for Smart Investing
TipRanks
6 days ago
Eli Lilly jumps as results from weight-loss pill study rival competitor’s
TipRanks
6 days ago
JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics
TipRanks
9 days ago
Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill
Zacks
9 days ago
NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback
Investor's Business Daily
2 months ago
AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.
MT Newswires
2 months ago
William Blair Initiates Structure Therapeutics at Outperform
GlobeNewswire
2 months ago
Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights
Motley Fool
2 months ago
Why Structure Therapeutics Stock Was Stumbling This Week
Compare GPCR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GPCR Structure Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.